PDS Biotech is a clinical-stage immunotherapeutic company developing treatments for cancer and infectious diseases. The proprietary T-cell activating platform Versamune is being employed to deliver
ImmunoGen Inc. is a clinical-stage biotechnology company focusing on the development of antibody-drug conjugate (ADC) as a treatment for cancer. The lead pipeline is mirvetuximab
Purple Biotech Ltd., a clinical-stage company, is developing treatments for cancers to overcome drug resistance. The lead oncology asset CM24 is a monoclonal antibody that
BeyondSpring Inc. is an early-stage clinical trial biopharmaceutical company developing immuno-oncology therapies (anti-cancer drugs). The main pipeline is Plinabulin, an anti-cancer drug that is being
Cytokinetics (CYTK), is a late clinical-stage biopharmaceutical company focusing on the development and commercialization of muscle activators and inhibitors as therapeutics for cardiovascular disorders. These
Formerly known as Impel Neuropharma Inc, Impel Pharmaceuticals Inc is a commercial-stage biopharmaceutical company, developing and commercializing treatments for central nervous system disorders in the
ATAI Life Sciences is a clinical-stage biopharmaceutical company focusing on the development of therapeutic solutions for various mental health disorders including treatment-resistant depression (TRD). ATAI
EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax stock included in MSCI Indexes 08.06.2023 / 18:00 CET/CEST The issuer is solely responsible for the content of
EQS-News: ABIVAX / Key word(s): AGM/EGM Abivax releases the results of its June 5, 2023 ordinary and extraordinary general meeting 08.06.2023 / 16:21 CET/CEST The
EQS-News: ABIVAX / Key word(s): Personnel Abivax appoints Ida Hatoum as Chief People Officer 08.06.2023 / 16:20 CET/CEST The issuer is solely responsible for the